Glaukos Corporation GKOS
237.31 USD -0.79 (-0.33%)
Regular-session close
237.31 0.00 0.00%
After hours · Nov 20, 5:23 PM ET
233.40 Day range 244.55
95.20 52-week range 247.16
- YTD
- +110.18%
- 1 year
- +149.28%
Benzinga news
benzinga.com BTIG Maintains Buy on Glaukos, Raises Price Target to $252 BTIG analyst Ryan Zimmerman maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $234 to $252.
benzinga.com Benzinga's 'Stock Whisper' Index: Five Stocks Investors Secretly Monitor But Don't Talk About Yet The Stock Whisper Index is a market indicator highlighting stocks that are attracting heightened interest from traders and investors.benzinga.com HC Wainwright & Co. Maintains Buy on Glaukos, Raises Price Target to $248 HC Wainwright & Co. analyst Yi Chen maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $195 to $248.
benzinga.com JP Morgan Maintains Overweight on Glaukos, Raises Price Target to $240 JP Morgan analyst Allen Gong maintains Glaukos (NYSE:GKOS) with a Overweight and raises the price target from $200 to $240.
benzinga.com Citigroup Maintains Buy on Glaukos, Raises Price Target to $247 Citigroup analyst Joanne Wuensch maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $225 to $247.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Glaukos (NYSE:GKOS) shares rose 30.8% to $237.26 during Thursday's regular session. The company's market cap stands at $10.7 billion. The company's, Q3 earnings came out yesterday. Teladoc…benzinga.com Truist Securities Maintains Buy on Glaukos, Raises Price Target to $255 Truist Securities analyst Richard Newitter maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $215 to $255.
benzinga.com Huntington Ingalls, Crocs, Carvana, Insmed And Other Big Stocks Moving Higher On Thursday Stocks rallied on strong earnings and raised guidance, led by Huntington Ingalls, Porch, Teladoc and Crocs, despite the Dow falling 150 points.benzinga.com Wells Fargo Maintains Overweight on Glaukos, Raises Price Target to $226 Wells Fargo analyst Larry Biegelsen maintains Glaukos (NYSE:GKOS) with a Overweight and raises the price target from $178 to $226.
benzinga.com Piper Sandler Reiterates Overweight on Glaukos, Raises Price Target to $240 Piper Sandler analyst Adam Maeder reiterates Glaukos (NYSE:GKOS) with a Overweight and raises the price target from $195 to $240.
benzinga.com Glaukos Analysts Boost Their Forecasts Following Better-Than-Expected Q3 Earnings Glaukos beat Q3 estimates, raised FY26 sales guidance to $775M-$785M, and shares jumped 17.4%; analysts lifted price targets.benzinga.com Stifel Maintains Buy on Glaukos, Raises Price Target to $225 Stifel analyst Tom Stephan maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $190 to $225.
benzinga.com BTIG Maintains Buy on Glaukos, Raises Price Target to $234 BTIG analyst Ryan Zimmerman maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $205 to $234.
benzinga.com Microsoft To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Thursday Analysts raised targets for Microsoft, VF, Glaukos, Hilton, AxoGen and Brinker; Renasant’s target was cut and its rating downgraded.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Mesoblast (NASDAQ:MESO) stock rose 16.2% to $15.57 during Thursday's pre-market session. The market value of their outstanding shares is at $1.7 billion. Glaukos (NYSE:GKOS) stock rose 15.75%…benzinga.com Needham Maintains Buy on Glaukos, Raises Price Target to $251 Needham analyst David Saxon maintains Glaukos (NYSE:GKOS) with a Buy and raises the price target from $201 to $251.
benzinga.com Why Glaukos Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket Glaukos surged 17.4% premarket after strong Q3 results and raised FY26 sales guidance; INLF, NCPL and PCLA also rallied.
benzinga.com Glaukos (GKOS) Stock Jumps 17% After Hours: What's Going On? Glaukos shares jump 17.61% after hours as third-quarter earnings beat estimates and the company raises 2026 sales guidance.
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Lakewood-Amedex (NASDAQ:LABT) stock rose 20.4% to $0.34 during Wednesday's after-market session. Glaukos (NYSE:GKOS) stock rose 16.85% to $212.01. The company's market cap stands at $10.6…benzinga.com Glaukos Raises FY2026 Sales Guidance from $680.000M-$700.000M to $775.000M-$785.000M vs $691.624M Est Glaukos (NYSE:GKOS) raises FY2026 sales outlook from $680.000 million-$700.000 million to $775.000 million-$785.000 million vs $691.624 million estimate.
benzinga.com Glaukos Q3 Adj. EPS $0.47 Beats $(0.09) Estimate, Sales $211.030M Beat $168.048M Estimate Glaukos (NYSE:GKOS) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $(0.09) by 622.22 percent. This is a 393.75 percent increase over losses of $(0.16) per…
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
